LGALS9 and neoplasm: ( 22 ) In contrast, NK cell activity is inhibited following the stimulation of its receptors PD-1, TIM3, and CD96 by their ligands PD-L1, Galectin-9, and CD122/CD155, respectively, contributing to tumor immune evasion.